These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 5805885)

  • 41. Shock following acute myocardial infarction.
    Panton WD
    Can Med Assoc J; 1966 Jan; 94(4):198-9. PubMed ID: 5901166
    [No Abstract]   [Full Text] [Related]  

  • 42. Some observations on the alteration of the adhesiveness of human blood platelets after infusion with low molecular weight dextran.
    Lal HB; Caroli RK; Sengupta D; Basumalik SN; Khan MA; Malik RN; Warrik HP
    J Assoc Physicians India; 1968 Aug; 16(8):523-7. PubMed ID: 5700157
    [No Abstract]   [Full Text] [Related]  

  • 43. [Cardiogenic shock in acute myocardial infarct].
    Malík J; Murín J; Kasper J; Mikla F
    Vnitr Lek; 1997 Jun; 43(6):366-8. PubMed ID: 9601866
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Personal experience with low molecular weight dextran, "Rheomacrodex", in the treatment of acute vascular obstructions].
    Fabra Jiménez L
    Rev Esp Cardiol; 1966 Apr; 19(2):189-97. PubMed ID: 5945474
    [No Abstract]   [Full Text] [Related]  

  • 45. Cardiogenic shock after acute myocardial infarction. Incidence and mortality from a community-wide perspective, 1975 to 1988.
    Goldberg RJ; Gore JM; Alpert JS; Osganian V; de Groot J; Bade J; Chen Z; Frid D; Dalen JE
    N Engl J Med; 1991 Oct; 325(16):1117-22. PubMed ID: 1891019
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Cardiogenic shock in acute myocardial infarction--what we know in 2005].
    Vojácek J; Bis J
    Cas Lek Cesk; 2005; 144 Suppl 3():30-2. PubMed ID: 16335260
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Importance of regional circulation for treatment of cardiogenic shock].
    Schröder R
    Arzneimittelforschung; 1969 May; 19(5):797-9. PubMed ID: 4308254
    [No Abstract]   [Full Text] [Related]  

  • 48. Group II. Acute myocardial infarction treated with low molecular weight dextran. (Lomodex-Tata Fison & Co., ltd). A controled study alongwith some observations on its effects on some laboratory parameters.
    Lal HB; Caroli RK
    Indian J Med Res; 1968 Jul; 56(7 Suppl):1116-9. PubMed ID: 4881517
    [No Abstract]   [Full Text] [Related]  

  • 49. Circulatory effects of digoxin, acid-base correction, and volume loading in cardiogenic shock.
    Muir AL; Anderton JL; Lawrie DM; Donald KW
    Br Heart J; 1969 Nov; 31(6):794. PubMed ID: 5358171
    [No Abstract]   [Full Text] [Related]  

  • 50. Shock complicating myocardial infarction.
    Shubin H
    Calif Med; 1965 Nov; 103(5):311-2. PubMed ID: 5834274
    [No Abstract]   [Full Text] [Related]  

  • 51. Temporal trends in cardiogenic shock complicating acute myocardial infarction.
    Goldberg RJ; Samad NA; Yarzebski J; Gurwitz J; Bigelow C; Gore JM
    N Engl J Med; 1999 Apr; 340(15):1162-8. PubMed ID: 10202167
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Cardiogenic shock--severe complication of myocardial infarction].
    Varpula M; Tierala I
    Duodecim; 2010; 126(18):2121-30. PubMed ID: 21072959
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Low molecular weight dextran im epidemic hemorrhagic fever].
    Wang HW
    Zhonghua Yi Xue Za Zhi; 1973; 6():355-8. PubMed ID: 4205868
    [No Abstract]   [Full Text] [Related]  

  • 54. Trends in management and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock.
    Babaev A; Frederick PD; Pasta DJ; Every N; Sichrovsky T; Hochman JS;
    JAMA; 2005 Jul; 294(4):448-54. PubMed ID: 16046651
    [TBL] [Abstract][Full Text] [Related]  

  • 55. B-type natriuretic peptide and its molecular precursor in myocardial infarction complicated by cardiogenic shock.
    Hejmdal A; Boesgaard S; Lindholm MG; Goetze JP
    J Card Fail; 2007 Apr; 13(3):184-8. PubMed ID: 17448415
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Recent magnitude of and temporal trends (1994-1997) in the incidence and hospital death rates of cardiogenic shock complicating acute myocardial infarction: the second national registry of myocardial infarction.
    Goldberg RJ; Gore JM; Thompson CA; Gurwitz JH
    Am Heart J; 2001 Jan; 141(1):65-72. PubMed ID: 11136488
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Observations and experiences in treatment of shock states with dextran of low molecular weight and corticosteroids in high doses].
    Serra GC; Simone M
    Acta Anaesthesiol; 1965; 16():Suppl 4:195+. PubMed ID: 5899705
    [No Abstract]   [Full Text] [Related]  

  • 58. [Persistence and renal excretions of low molecular weight dextran in newborns and infants].
    Emmrich P; Jüngst BK; Appel W
    Z Kinderheilkd; 1969; 106(4):298-307. PubMed ID: 5810012
    [No Abstract]   [Full Text] [Related]  

  • 59. Response of cases with acute myocardial infarction to infusion with low-molecular weight dextran (lomodex).
    Lal HB; Caroli RK; Malik RN; Sengupta D; Basumalik SN; Warrik HP; Behl AN
    Indian J Med Sci; 1968 Apr; 22(4):214-9. PubMed ID: 4875866
    [No Abstract]   [Full Text] [Related]  

  • 60. [Pharmacological treatment of shock: achievements and controversies].
    Aleksandrow D
    Pol Tyg Lek; 1971 Dec; 26(52):2009-10. PubMed ID: 5139585
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.